Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
Identifieur interne : 001F16 ( Ncbi/Merge ); précédent : 001F15; suivant : 001F17Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
Auteurs : Adoraci N Navarro-Torné ; Finnian Hanrahan ; Barbara Kerstiëns ; Pilar Aguar ; Line MatthiessenSource :
- Emerging infectious diseases [ 1080-6059 ] ; 2019.
Descripteurs français
- KwdFr :
- MESH :
- immunologie : Vaccins antigrippaux, Virus de la grippe A.
- épidémiologie : Grippe humaine.
- Biotechnologie, Grippe humaine, Humains, Recherche, Santé publique, Union européenne.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Influenza Vaccines.
- epidemiology : Influenza, Human.
- immunology : Influenza A virus.
- prevention & control : Influenza, Human.
- Biotechnology, European Union, Humans, Public Health, Research, Vaccinology.
Abstract
Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health.
DOI: 10.3201/eid2502.180359
PubMed: 30666948
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000177
- to stream PubMed, to step Curation: 000177
- to stream PubMed, to step Checkpoint: 000102
Links to Exploration step
pubmed:30666948Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.</title><author><name sortKey="Navarro Torne, Adoraci N" sort="Navarro Torne, Adoraci N" uniqKey="Navarro Torne A" first="Adoraci N" last="Navarro-Torné">Adoraci N Navarro-Torné</name></author><author><name sortKey="Hanrahan, Finnian" sort="Hanrahan, Finnian" uniqKey="Hanrahan F" first="Finnian" last="Hanrahan">Finnian Hanrahan</name></author><author><name sortKey="Kerstiens, Barbara" sort="Kerstiens, Barbara" uniqKey="Kerstiens B" first="Barbara" last="Kerstiëns">Barbara Kerstiëns</name></author><author><name sortKey="Aguar, Pilar" sort="Aguar, Pilar" uniqKey="Aguar P" first="Pilar" last="Aguar">Pilar Aguar</name></author><author><name sortKey="Matthiessen, Line" sort="Matthiessen, Line" uniqKey="Matthiessen L" first="Line" last="Matthiessen">Line Matthiessen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30666948</idno><idno type="pmid">30666948</idno><idno type="doi">10.3201/eid2502.180359</idno><idno type="wicri:Area/PubMed/Corpus">000177</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000177</idno><idno type="wicri:Area/PubMed/Curation">000177</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000177</idno><idno type="wicri:Area/PubMed/Checkpoint">000102</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000102</idno><idno type="wicri:Area/Ncbi/Merge">001F16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.</title><author><name sortKey="Navarro Torne, Adoraci N" sort="Navarro Torne, Adoraci N" uniqKey="Navarro Torne A" first="Adoraci N" last="Navarro-Torné">Adoraci N Navarro-Torné</name></author><author><name sortKey="Hanrahan, Finnian" sort="Hanrahan, Finnian" uniqKey="Hanrahan F" first="Finnian" last="Hanrahan">Finnian Hanrahan</name></author><author><name sortKey="Kerstiens, Barbara" sort="Kerstiens, Barbara" uniqKey="Kerstiens B" first="Barbara" last="Kerstiëns">Barbara Kerstiëns</name></author><author><name sortKey="Aguar, Pilar" sort="Aguar, Pilar" uniqKey="Aguar P" first="Pilar" last="Aguar">Pilar Aguar</name></author><author><name sortKey="Matthiessen, Line" sort="Matthiessen, Line" uniqKey="Matthiessen L" first="Line" last="Matthiessen">Line Matthiessen</name></author></analytic><series><title level="j">Emerging infectious diseases</title><idno type="eISSN">1080-6059</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biotechnology</term><term>European Union</term><term>Humans</term><term>Influenza A virus (immunology)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Public Health</term><term>Research</term><term>Vaccinology</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Biotechnologie</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Recherche</term><term>Santé publique</term><term>Union européenne</term><term>Vaccins antigrippaux (immunologie)</term><term>Virus de la grippe A (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biotechnology</term><term>European Union</term><term>Humans</term><term>Public Health</term><term>Research</term><term>Vaccinology</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Biotechnologie</term><term>Grippe humaine</term><term>Humains</term><term>Recherche</term><term>Santé publique</term><term>Union européenne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30666948</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>02</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2502.180359</ELocationID><Abstract><AbstractText>Influenza virus infections are a major public health threat. Vaccination is available, but unpredictable antigenic changes in circulating strains require annual modification of seasonal influenza vaccines. Vaccine effectiveness has proven limited, particularly in certain groups, such as the elderly. Moreover, preparedness for upcoming pandemics is challenging because we can predict neither the strain that will cause the next pandemic nor the severity of the pandemic. The European Union fosters research and innovation to develop novel vaccines that evoke broadly protective and long-lasting immune responses against both seasonal and pandemic influenza, underpinned by a political commitment to global public health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Navarro-Torné</LastName><ForeName>Adoración</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hanrahan</LastName><ForeName>Finnian</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kerstiëns</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Aguar</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Matthiessen</LastName><ForeName>Line</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D001709" MajorTopicYN="Y">Biotechnology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012106" MajorTopicYN="Y">Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078782" MajorTopicYN="N">Vaccinology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">European Union</Keyword><Keyword MajorTopicYN="Y">biomedical research</Keyword><Keyword MajorTopicYN="Y">drug legislation</Keyword><Keyword MajorTopicYN="Y">financial support</Keyword><Keyword MajorTopicYN="Y">global health</Keyword><Keyword MajorTopicYN="Y">influenza</Keyword><Keyword MajorTopicYN="Y">influenza pandemic</Keyword><Keyword MajorTopicYN="Y">influenza vaccines</Keyword><Keyword MajorTopicYN="Y">innovation</Keyword><Keyword MajorTopicYN="Y">public health</Keyword><Keyword MajorTopicYN="Y">vaccines</Keyword><Keyword MajorTopicYN="Y">viruses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30666948</ArticleId><ArticleId IdType="doi">10.3201/eid2502.180359</ArticleId><ArticleId IdType="pmc">PMC6346458</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Viruses. 2014 Jul 17;6(7):2735-61</Citation><ArticleIdList><ArticleId IdType="pubmed">25036462</ArticleId></ArticleIdList></Reference><Reference><Citation>J Control Release. 2016 Jun 28;232:42-50</Citation><ArticleIdList><ArticleId IdType="pubmed">27080572</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2017 Oct 30;65(10):1644-1651</Citation><ArticleIdList><ArticleId IdType="pubmed">29020179</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2017 Oct 17;47(4):599-603</Citation><ArticleIdList><ArticleId IdType="pubmed">29045889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jun 3;34(26):2926-2933</Citation><ArticleIdList><ArticleId IdType="pubmed">27038130</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Drug Deliv. 2012 Sep;9(9):1051-67</Citation><ArticleIdList><ArticleId IdType="pubmed">22708875</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk Anal. 2017 Jan;37(1):4-19</Citation><ArticleIdList><ArticleId IdType="pubmed">27214756</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Virol. 2016 Apr;17:95-103</Citation><ArticleIdList><ArticleId IdType="pubmed">26927813</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2017 Jan 3;35(1):191-198</Citation><ArticleIdList><ArticleId IdType="pubmed">27789145</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Feb 24;34(9):1139-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26808648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Dec 3;378(9807):1917-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22078723</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Biotechnol. 2017 Nov 10;17(1):79</Citation><ArticleIdList><ArticleId IdType="pubmed">29126399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2018 Mar 31;391(10127):1285-1300</Citation><ArticleIdList><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Dec;14(12):1196-207</Citation><ArticleIdList><ArticleId IdType="pubmed">25455987</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1853-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26755593</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2017 Jun;74 Suppl 1:S101-S107</Citation><ArticleIdList><ArticleId IdType="pubmed">28646948</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2015 Jun;21(6):1086-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25988813</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Immunol. 2014 Aug;29:38-42</Citation><ArticleIdList><ArticleId IdType="pubmed">24769424</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2014 Aug 18;6(8):3159-80</Citation><ArticleIdList><ArticleId IdType="pubmed">25196381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageing Res Rev. 2011 Jul;10(3):379-88</Citation><ArticleIdList><ArticleId IdType="pubmed">21055484</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2018 Sep;12(5):558-565</Citation><ArticleIdList><ArticleId IdType="pubmed">29727518</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Dec 5;31(50):6030-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24095882</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Microbiol. 2013 Jul;21(7):350-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23685068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2012 Jan;12(1):36-44</Citation><ArticleIdList><ArticleId IdType="pubmed">22032844</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2017 Oct;22(41):</Citation><ArticleIdList><ArticleId IdType="pubmed">29043961</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2018 Jan 4;378(1):7-9</Citation><ArticleIdList><ArticleId IdType="pubmed">29185857</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayo Clin Proc. 2010 Mar;85(3):257-73</Citation><ArticleIdList><ArticleId IdType="pubmed">20118381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2015 Mar;14(3):167-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25722244</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583</Citation><ArticleIdList><ArticleId IdType="pubmed">29109276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccines (Basel). 2015 Apr 24;3(2):373-89</Citation><ArticleIdList><ArticleId IdType="pubmed">26343192</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2017 May;11(3):194-201</Citation><ArticleIdList><ArticleId IdType="pubmed">28146323</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Pharm Biopharm. 2015 Aug;94:251-63</Citation><ArticleIdList><ArticleId IdType="pubmed">26047796</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2017 May 15;215(10):1527-1535</Citation><ArticleIdList><ArticleId IdType="pubmed">28368530</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2016 Dec 15;63(12):1564-1573</Citation><ArticleIdList><ArticleId IdType="pubmed">27702768</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2017 Mar;96(11):e6339</Citation><ArticleIdList><ArticleId IdType="pubmed">28296763</ArticleId></ArticleIdList></Reference><Reference><Citation>mBio. 2018 Jan 16;9(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">29339427</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 24;9(7):e102505</Citation><ArticleIdList><ArticleId IdType="pubmed">25057914</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2012 Mar;91(3):418-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22318619</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Jun 05;10(6):e0127969</Citation><ArticleIdList><ArticleId IdType="pubmed">26046664</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2018 Jan 25;36(4):442-452</Citation><ArticleIdList><ArticleId IdType="pubmed">29287683</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Aff (Millwood). 2016 Nov 1;35(11):2124-2132</Citation><ArticleIdList><ArticleId IdType="pubmed">27733424</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2018 Sep;12(5):551-557</Citation><ArticleIdList><ArticleId IdType="pubmed">29722140</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2015 Mar 11;17(3):295-300</Citation><ArticleIdList><ArticleId IdType="pubmed">25766291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Nov 21;34(48):5845-5854</Citation><ArticleIdList><ArticleId IdType="pubmed">27793486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Prev Med Hyg. 2016 Sep;57(3):E115-E120</Citation><ArticleIdList><ArticleId IdType="pubmed">27980374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Aguar, Pilar" sort="Aguar, Pilar" uniqKey="Aguar P" first="Pilar" last="Aguar">Pilar Aguar</name><name sortKey="Hanrahan, Finnian" sort="Hanrahan, Finnian" uniqKey="Hanrahan F" first="Finnian" last="Hanrahan">Finnian Hanrahan</name><name sortKey="Kerstiens, Barbara" sort="Kerstiens, Barbara" uniqKey="Kerstiens B" first="Barbara" last="Kerstiëns">Barbara Kerstiëns</name><name sortKey="Matthiessen, Line" sort="Matthiessen, Line" uniqKey="Matthiessen L" first="Line" last="Matthiessen">Line Matthiessen</name><name sortKey="Navarro Torne, Adoraci N" sort="Navarro Torne, Adoraci N" uniqKey="Navarro Torne A" first="Adoraci N" last="Navarro-Torné">Adoraci N Navarro-Torné</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001F16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:30666948
|texte= Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:30666948" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |